Stealth BioTherapeutics
Brian Blakey is the Chief Business Officer of Stealth BioTherapeutics. He brings 30 years of pharmaceutical marketing, alliance development and operations experience to Stealth. Previously, Brian was the COO of Element Marketing Group and the Vice President of Commercial Development at Salutria (formerly AtheroGenics). He has held senior positions at other pharmaceutical companies, including GlaxoSmithKline. Brian holds a Doctor of Pharmacy degree from the University of Florida.
This person is not in any offices
Stealth BioTherapeutics
1 followers
Stealth BioTherapeutics is an innovative biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging.